Paradigm claims that iPPS is a 1B market for OA and that the drug is "statistically significant" and DMOAD. However, there doesn't appear to be any interest in partnering for OA...how could that be?
AGM Meeting
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $101.4M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $130.7K | 465.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 117553 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 272 | 4 |
View Market Depth
| Last trade - 12.33pm 04/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |